Search Page

1

Cite

Share

Psychedelics as anti-inflammatory agents.

Flanagan TW, Nichols CD. Flanagan TW, et al. Among authors: nichols cd. Int Rev Psychiatry. 2018 Aug;30(4):363-375. doi: 10.1080/09540261.2018.1481827. Epub 2018 Aug 13. Int Rev Psychiatry. 2018. PMID: 30102081

Cite

Share

2

Cite

Share

Serotonin 5-hydroxytryptamine(2A) receptor activation suppresses tumor necrosis factor-alpha-induced inflammation with extraordinary potency.

Yu B, Becnel J, Zerfaoui M, Rohatgi R, Boulares AH, Nichols CD. Yu B, et al. Among authors: nichols cd. J Pharmacol Exp Ther. 2008 Nov;327(2):316-23. doi: 10.1124/jpet.108.143461. Epub 2008 Aug 15. J Pharmacol Exp Ther. 2008. PMID: 18708586

Cite

Share

3

Cite

Share

Serotonin 5-HT(2A) Receptor Function as a Contributing Factor to Both Neuropsychiatric and Cardiovascular Diseases.

Nichols CD. Nichols CD. Cardiovasc Psychiatry Neurol. 2009;2009:475108. doi: 10.1155/2009/475108. Epub 2009 Oct 13. Cardiovasc Psychiatry Neurol. 2009. PMID: 20029624 Free PMC article.

Cite

Share

4

Cite

Share

Human disease models in Drosophila melanogaster and the role of the fly in therapeutic drug discovery.

Pandey UB, Nichols CD. Pandey UB, et al. Among authors: nichols cd. Pharmacol Rev. 2011 Jun;63(2):411-36. doi: 10.1124/pr.110.003293. Epub 2011 Mar 17. Pharmacol Rev. 2011. PMID: 21415126 Free PMC article. Review.

Cite

Share

5

Cite

Share

Serotonin 5-HT2A receptor activation blocks TNF-α mediated inflammation in vivo.

Nau F Jr, Yu B, Martin D, Nichols CD. Nau F Jr, et al. Among authors: nichols cd. PLoS One. 2013 Oct 2;8(10):e75426. doi: 10.1371/journal.pone.0075426. eCollection 2013. PLoS One. 2013. PMID: 24098382 Free PMC article.

Cite

Share

6

Cite

Share

Psychedelics Recruit Multiple Cellular Types and Produce Complex Transcriptional Responses Within the Brain.

Martin DA, Nichols CD. Martin DA, et al. Among authors: nichols cd. EBioMedicine. 2016 Sep;11:262-277. doi: 10.1016/j.ebiom.2016.08.049. Epub 2016 Sep 3. EBioMedicine. 2016. PMID: 27649637 Free PMC article.

Cite

Share

7

Cite

Share

Psychedelics as Medicines: An Emerging New Paradigm.

Nichols DE, Johnson MW, Nichols CD. Nichols DE, et al. Among authors: nichols cd. Clin Pharmacol Ther. 2017 Feb;101(2):209-219. doi: 10.1002/cpt.557. Epub 2016 Dec 26. Clin Pharmacol Ther. 2017. PMID: 28019026 Review.

Cite

Share

8

Cite

Share

The Effects of Hallucinogens on Gene Expression.

Martin DA, Nichols CD. Martin DA, et al. Among authors: nichols cd. Curr Top Behav Neurosci. 2018;36:137-158. doi: 10.1007/7854_2017_479. Curr Top Behav Neurosci. 2018. PMID: 28677095 Review.

Cite

Share

9

Cite

Share

Psychedelic Drugs in Biomedicine.

Kyzar EJ, Nichols CD, Gainetdinov RR, Nichols DE, Kalueff AV. Kyzar EJ, et al. Among authors: nichols cd, nichols de. Trends Pharmacol Sci. 2017 Nov;38(11):992-1005. doi: 10.1016/j.tips.2017.08.003. Epub 2017 Sep 22. Trends Pharmacol Sci. 2017. PMID: 28947075 Review.

Cite

Share

10

Cite

Share

Microdosing psychedelics: More questions than answers? An overview and suggestions for future research.

Kuypers KP, Ng L, Erritzoe D, Knudsen GM, Nichols CD, Nichols DE, Pani L, Soula A, Nutt D. Kuypers KP, et al. Among authors: nichols cd, nichols de. J Psychopharmacol. 2019 Sep;33(9):1039-1057. doi: 10.1177/0269881119857204. Epub 2019 Jul 14. J Psychopharmacol. 2019. PMID: 31303095 Free PMC article. Review.

Cite

Share